Elevate your local knowledge

Sign up for the iNFOnews newsletter today!

Select Region

Selecting your primary region ensures you get the stories that matter to you first.

EpiPen and EpiPen Jr. subject to recall because of possible defective part

EpiPen and EpiPen Jr. subject to recall because of possible defective part | iNFOnews.ca
FILE - If Naloxone is free, why not diabetes, asthma or anti-allergy medication? A Regional District of Okanagan SImilkameen Board of Directors resolution will make that pitch to the province, if approved at this week's board meeting. AP Photo/Rich Pedroncelli, File

KIRKLAND, Que. – Pfizer Canada has issued a recall on one lot of EpiPen and one lot of EpiPen Jr. auto-injectors that may contain a faulty part.

The company says there have been two international cases reported where a defective part prevented the auto-injector from activating.

They say there haven't been any confirmed cases involving lots of the injectors distributed in Canada.

The products involved in the recall are EpiPen auto-injectors with an expiry date of May 2017, and EpiPen Jr. auto-injectors with an expiry date of March 2017.

The company says that in total, more than 100,000 products that could be affected were distributed in Canada.

EpiPens deliver an emergency dose of adrenaline to people at risk of a serious allergic reaction.

News from © iNFOnews.ca, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Kim Anderson

Originally from a northern B.C. town that boasts a giant fly fishing rod and a population of 3,100, Kim moved to Kamloops in 2011 to attend Thompson Rivers University. Kim is as comfortable behind a camera as she is writing on her laptop. After graduating with a degree in journalism, Kim has been busy with an independent freelance writing project and photography work. Contact Kim at kanderson@infonews.ca with news tips or story ideas.

Kim's Stories

Related Articles